The Foundation of Sarcoidosis Research (FSR) maintains a strong Scientific Advisory Board (SAB) composed of world renowned key opinion leaders within the fields of sarcoidosis, medical research, therapy development, and medical practice. The SAB helps advance FSR towards its mission dedicated to finding a cure for this disease and to improving care for sarcoidosis patients.

Robert Baughman, MD
University of Cincinnati
Marc Judson, MD
Department of Medicine, MC-91
Albany Medical College
Ulrich Costabel, MD, FERS
University of Duisburg-Essen
Ruhrlandklinik Essen Germany
Craig Lipset
Head of Clinical Innovation
Daniel Culver, DO
Chief Director of Pulmonary Sarcoid Clinic
Cleveland Clinic
Lisa Maier, MD
National Jewish Health
Seamas Donnelly, MD
Professor in Clinical Medicine and Head of Department
Trinity College Dublin
 Dave Moller, MD
Johns Hopkins University
Wonder Drake, MD
Associate Professor of Medicine
Vanderbilt University
Adam Morgenthau, MD
Icahn School of Medicine at Mount Sinai
 Marjolein Drent, MD, PhD:
St.Antonius Hospital Nieuwegein and University Maastricht,
FHML, Dept of Pharmacology and
Toxicology, Maastricht, The Netherlands
President of WASOG
Misha Rosenbach, MD
University of Pennsylvania
Andrew Fontenot, MD
University of Colorado
Milton Rossman, MD
University of Pennsylvania
Skip Garcia, MD
Senior Vice President for Health Services
University of Arizona
Leslie Serchuck, MD
Children’s Hospital of Philadelphia
Edward Chen, MD
Johns Hopkins University
Barney Stern, MD
University of Maryland
Elliott Crouser, MD
Ohio State University
Dominique Valeyre, MD
Hôpital Avicenne
W. Ennis James, MD
Medical University of South Carolina

Please note: While FSR receives guidance and input from our Scientific Advisory Board (SAB), it is not to be implied that all SAB members support or are in agreement in each specific FSR initiative or approach. As with most professional groups, members may have differing perspectives and opinions on various issues. FSR’s intent is always to work toward consensus with our experts as much as feasible while addressing patient and research needs.

Meet our staff.